"Influence of Remicade (infliximab) in the skin proteome of psoriatic patients".
Phase of Trial: Phase IV
Latest Information Update: 25 Feb 2012
At a glance
- Drugs Infliximab (Primary)
- Indications Plaque psoriasis
- Focus Biomarker; Therapeutic Use
- 25 Feb 2012 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
- 16 Jun 2011 New trial record